Back to School: How biopharma can reboot drug development. Access exclusive analysis here
PDLI and partner Hoffmann-La Roche Inc. (Nutley, N.J.) presented results of a Phase I/II double-blind placebo-controlled trial at the meeting
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury